title: Clinical management of patients with recurrent viral hepatitis after liver transplantation.
abstract: Liver transplantation is indicated in end-stage chronic viral liver disease, but unless adequate prophylaxis is administered, the patient will in most cases develop recurrent hepatitis B (HBV) and C (HCV) virus infection. Today, patients receiving prophylaxis using nucleoside analogue drugs with or without specific immune globulin drugs in connection with orthotopic liver transplantation for HBV related cirrhosis, present low risk of relapse and high 5-10 year survival rates. Lamivudine was the first drug used in the prophylactic treatment, but this drug has increasingly been combined with or replaced by adefovir due to the low genetic barrier, which causes viral resistance. Most patients develop viral recurrence after orthotopic liver transplantation for HCV related cirrhosis, and in an elevated number of cases, cirrhosis and hepatic insufficiency set in after a few years. Prophylaxis before transplantation and pre-emptive treatment using interferon and ribavirin present numerous side effects resulting in reduction of doses and suspension of therapy, with consequently low sustained virological remission rates and risk of rejection.The treatment is better tolerated by patients with histologically confirmed chronic disease, but also in these patients virological remission rates are low. This pathology requires new therapeutic protocols and/or new drugs in order to obtain better compliance and better responses.
authors: Department of Infectious Diseases, San Donato Hospital, Arezzo, Italy.
authors: M
authors: M
authors: Caremani
authors: D
authors: D
authors: Tacconi
authors: P
authors: P
authors: Giorni
authors: L
authors: L
authors: Lapini
authors: S
authors: S
authors: Corradini
authors: R
authors: R
authors: Giaccherini
keywords: Cirrhosis; Interferon; Transplantation
references: Transplantation. 2005 Jun 15;79(11):1631-3
references: 15940056
references: Liver Transpl. 2005 May;11(5):532-8
references: 15838891
references: Hepatology. 2002 Mar;35(3):601-8
references: 11870373
references: Hepatobiliary Pancreat Dis Int. 2003 Feb;2(1):54-8
references: 14599930
references: J Hepatol. 2003 Apr;38(4):533-40
references: 12663250
references: Transplantation. 2004 Oct 15;78(7):955-63
references: 15480158
references: N Engl J Med. 1996 Mar 28;334(13):815-20
references: 8596547
references: Radiology. 2003 Dec;229(3):806-10
references: 14576444
references: Dig Liver Dis. 2002 Sep;34(9):640-8
references: 12405251
references: Liver Transpl. 2001 Oct;7(10):870-6
references: 11679985
references: Liver Transpl. 2003 Sep;9(9):905-15
references: 12942451
references: J Hepatol. 2004 Nov;41(5):830-6
references: 15519657
references: World J Gastroenterol. 2005 Nov 21;11(43):6787-91
references: 16425385
references: Liver Transpl. 2005 Apr;11(4):402-9
references: 15776431
references: Hepatology. 1994 Oct;20(4 Pt 1):773-9
references: 7927216
references: J Hepatol. 2003 Sep;39(3):389-96
references: 12927925
references: Radiographics. 2003 Sep-Oct;23(5):1093-114
references: 12975502
references: Transplant Proc. 2003 Dec;35(8):3042-4
references: 14697974
references: Liver Transpl. 2002 Oct;8(10 Suppl 1):S14-8
references: 12362293
references: Transplant Proc. 2001 Feb-Mar;33(1-2):1355-7
references: 11267325
references: Radiology. 2005 May;235(2):651-8
references: 15770040
references: Liver Transpl. 2002 Apr;8(4):362-9
references: 11965581
references: Hepatology. 1999 Jul;30(1):58-64
references: 10385639
references: Gut. 1999 Apr;44(4):575-8
references: 10075968
references: Hepatology. 1998 Sep;28(3):831-8
references: 9731580
references: Antivir Ther. 2004 Oct;9(5):679-93
references: 15535405
references: J Hepatol. 2005 Aug;43(2):200-2
references: 15975684